Security key
M74240116
NeuroSense Therapeutics Ltd. - *W EXP 11/10/202 (NRSNW)
CUSIP: M74240116
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / *W EXP 11/10/202
- Total 13F shares
- 78,600
- Total 13F value
- $16,135
- Share change
- -27,800
- SEC-reported price per share
- $0.21
- Number of holders
- 3
- Value change
- -$8,085
- Number of buys
- 2
- Number of sells
- 2
Report period
Q1 2025
Institutions
3
Top holders
3
NRSNW full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
NeuroSense Therapeutics Ltd. SEC filings
NeuroSense Therapeutics Ltd. company facts
Broader feeds
Reporting periods
Holder history for CUSIP M74240116
Recent filing periods:
Ownership snapshot
Top reported holders of NRSNW - NeuroSense Therapeutics Ltd. - *W EXP 11/10/202 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
CITADEL ADVISORS LLC
Disclosed value leader
CITADEL ADVISORS LLC
Comparable rows
0/15
Latest evidence
31 Dec 2024
13F
Highest disclosed value: $311,836
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
CITADEL ADVISORS LLC has the largest disclosed position value at $311.8K.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens CITADEL ADVISORS LLC's linked filing trail.
Disclosed position value
Top 5
CITADEL ADVISORS LLC
$311.8K
MORGAN STANLEY
$123.1K
JANE STREET GROUP, LLC
$77.6K
HRT FINANCIAL LP
$77K
XTX Topco Ltd
$50.3K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| CITADEL ADVISORS LLC |
13F
Company
|
—
mixed-class rows
|
$311,836
276,708 shares
mixed-class rows
|
— | 31 Dec 2024 |
| MORGAN STANLEY |
13F
Company
|
—
denominator unverified
|
$123,097
102,581 shares
|
— | 31 Dec 2024 |
| JANE STREET GROUP, LLC |
13F
Company
|
—
denominator unverified
|
$77,563
64,636 shares
|
— | 31 Dec 2024 |
| HRT FINANCIAL LP |
13F
Company
|
—
denominator unverified
|
$77,000
64,390 shares
|
— | 31 Dec 2024 |
| XTX Topco Ltd |
13F
Company
|
—
denominator unverified
|
$50,276
41,897 shares
|
— | 31 Dec 2024 |
| MEITAV INVESTMENT HOUSE LTD |
13F
Company
|
—
denominator unverified
|
$48,000
40,000 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
3
Shares
78,600
Rows available
3
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q1 2026 Across Filers
Q1 2026 holders
3
Q1 2025 holders
3
Holder diff
0
| Investor | Q1 2026 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend